Register entry
- Registered sites
- 3
- Active NDC listings
- 0
- Live patents
- 0
- Countries
- 2
- Base
- United States
Authorisation
Registered operations
Analytical testing1Labelling1Finished drug manufacture2Packaging1Repackaging1
Sites
Registered establishments
3| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| COTY LANCASTER SAM | 2 Etg 6 Avenue du Prince ALBERT II, Monaco, 98000, Monaco (MCO) | Finished drug manufacture | 1000298299401011325 |
| NOXELL CORPORATIONRegistrant: COTY LANCASTER SAM | 11050 York Road, HUNT VALLEY, Maryland (MD) 21030, United States (USA) | Analytical testing, Labelling, Finished drug manufacture, Packaging | 1111567003082997 |
| COTY US LLCRegistrant: COTY LANCASTER SAM | 1400 BROADWAY ROAD, SANFORD, North Carolina (NC) 27332, United States (USA) | Repackaging | 1025346039056361 |
Neighbours
Registered in the same town
3- Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.Sanford, NC
- Astellas Pharma US, Inc.Sanford, NC
- Pharmaceutics International, Inc.Hunt Valley, MD
Compare
Comparable companies in United States
- International Medication Systems, Ltd.3 sites · 2,801 NDC
- Alk-Abello, Inc.3 sites · 412 NDC
- Conopco, Inc. d/b/a Unilever3 sites · 374 NDC
- L. Perrigo Company3 sites · 243 NDC
- Epic Laboratories, LLC3 sites · 209 NDC
- Safecor Health, LLC3 sites · 103 NDC
- ProPharma Distribution, LLC.3 sites · 100 NDC
- B. Braun US Pharmaceutical Manufacturing LLC3 sites · 94 NDC
- Aurolife Pharma LLC3 sites · 70 NDC
- Elementis Specialties (India) Private Limited3 sites · 69 NDC
Enquiry
Common questions
- Is COTY LANCASTER SAM FDA approved?
- COTY LANCASTER SAM holds 3 FDA-registered establishments across 2 countries. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are COTY LANCASTER SAM's drugs manufactured?
- At registered sites in MCO, the United States. The FDA register lists Monaco; HUNT VALLEY, MD; SANFORD, NC. Registered operations: analytical testing, labelling, finished drug manufacture, packaging, repackaging.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.